Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavie Ader

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Blood|May 27, 2014
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisininsStéphane Jauréguiberry, Papa A Ndour, Camille Roussel, et al.
Emerging Infectious Diseases|April 22, 2015
Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013Stéphane Jauréguiberry, Marc Thellier, Papa Alioune Ndour, et al.
Clinical Genetics|June 28, 2019
FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlationsFlavie Ader, Pascal De Groote, Patricia Réant, et al.
Clinical Genetics|November 25, 2018
Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneityPascale Richard, Flavie Ader, Maguelonne Roux, et al.
Journal of Cardiac Failure|June 5, 2021
Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of NoncompactionMarie Cambon-Viala, Hilla Gerard, Karine Nguyen, et al.
Frontiers in Cardiovascular Medicine|May 19, 2022
Prognosis of Adults With Isolated Left Ventricular Non-Compaction: Results of a Prospective Multicentric StudyHilla Gerard, Nicolas Iline, Hélène Martel, et al.
Orphanet Journal of Rare Diseases|June 10, 2025
Comparison of two genetic strategies for diagnostic work-up of hypertrophic cardiomyopathy: impact on the diagnosis of Fabry disease or transthyretin amyloidosisAurélien Palmyre, Fairouz Koraichi, Flavie Ader, et al.
International Journal of Cardiology|November 16, 2024
Clinical impact of genetic testing in a large cohort of pediatric cardiomyopathiesFlavie Ader, Neil Derridj, Anne Claire Brehin, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 22, 2017
High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutationsJulien Thevenon, Gabriel Laurent, Flavie Ader, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Blood|May 27, 2014
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisininsStéphane Jauréguiberry, Papa A Ndour, Camille Roussel, et al.
Emerging Infectious Diseases|April 22, 2015
Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013Stéphane Jauréguiberry, Marc Thellier, Papa Alioune Ndour, et al.
Clinical Genetics|June 28, 2019
FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlationsFlavie Ader, Pascal De Groote, Patricia Réant, et al.
Clinical Genetics|November 25, 2018
Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneityPascale Richard, Flavie Ader, Maguelonne Roux, et al.
Journal of Cardiac Failure|June 5, 2021
Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of NoncompactionMarie Cambon-Viala, Hilla Gerard, Karine Nguyen, et al.
Frontiers in Cardiovascular Medicine|May 19, 2022
Prognosis of Adults With Isolated Left Ventricular Non-Compaction: Results of a Prospective Multicentric StudyHilla Gerard, Nicolas Iline, Hélène Martel, et al.
Orphanet Journal of Rare Diseases|June 10, 2025
Comparison of two genetic strategies for diagnostic work-up of hypertrophic cardiomyopathy: impact on the diagnosis of Fabry disease or transthyretin amyloidosisAurélien Palmyre, Fairouz Koraichi, Flavie Ader, et al.
International Journal of Cardiology|November 16, 2024
Clinical impact of genetic testing in a large cohort of pediatric cardiomyopathiesFlavie Ader, Neil Derridj, Anne Claire Brehin, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 22, 2017
High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutationsJulien Thevenon, Gabriel Laurent, Flavie Ader, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
Pageof 5